These findings suggest a potential role of GATAD2B in promoting chemoresistance of breast cancer cells in vitro, and role of GATAD2B as a potential predictive marker for chemoresistance in aggressive breast cancers. This evidence concerns the gene GATAD2B and breast carcinoma.